Navigation Links
University launches iPhone app to access HIV drug expertise
Date:11/15/2010

The University of Liverpool has launched an i-phone application, HIV iChart,that provides healthcare professionals and HIV patients with instant and easy access to information about drug interactions.

Based on the University-developed website (www.hiv-druginteractions.org), HIV iChart is a tool that provides HIV patients and healthcare professionals with immediate access to information on potential drug interactions between anti-HIV drugs and other medications that a patient with the disease may be taking.

In HIV therapy, patients take a number of anti-HIV medication (antiretrovirals) and may also take other drugs to treat co-existing diseases. Drug interactions can have an impact on the effectiveness of one or both drugs, and may also impact on the severity of the side effects of the medication. For this reason, some drugs should not be used, whilst others must be given with caution, possibly requiring adjustment or monitoring.

Professor David Back, Professor of Pharmacology, said: "We are delighted to launch this application for i-phones that will provide HIV patients and healthcare professionals with instant and easy access to information about HIV drug interactions that is relevant, reliable and up-to-date. HIV iChart can be used on a hospital ward or in a clinic, in primary-care units, health centres and the community. In addition to the HIV drugs interaction website, this new tool will increase awareness of how to manage the disease more effectively."

Dr Ian Williams, Chair of the British HIV Association (BHIVA), said: "This technology provides a marvellous opportunity to greatly increase the ease of access to drug interaction information. This is a way of helping to maintain best practice."

HIV iCharts is available free of charge and can be downloaded from the App store in iTunes (http://itunes.apple.com/gb/app/hiv-i...uo=2&mt=8&uo=2). The application is compatible with both the iPhone and iPod touch and only requires web access for the initial download and updates.

The application has been created by the HIV Pharmacology Group at the University of Liverpool and developed with eMedFusion, a division of the KnowledgePoint360 Group. It is supported by the Elton John AIDS Foundation, MSD and Janssen.

HIV iCharts was launched this week at the Tenth International Congress on Drug Therapy in HIV Infection which was held at the SECC in Glasgow.


'/>"/>

Contact: Sarah Stamper
sarah.stamper@liv.ac.uk
01-517-943-044
University of Liverpool
Source:Eurekalert

Related medicine news :

1. Louisiana State University Health Sciences Center research shows fish oil component given up to 5 hours after stroke limits brain damage
2. National Cancer Institute awards nearly $4 million to University of New Mexico Cancer Center
3. Hebrew University researchers discover expanded role for cancer-causing gene
4. 2010 Vanderbilt Prize awarded to Duke University researcher
5. University of Cincinnati neurotrauma team awarded $2.1M to test lab on a tube
6. National Medal of Science awarded to Stephen Benkovic of Penn State University
7. University of East Anglia makes cancer breakthrough
8. University of Miami receives grant to increase the number of family nurse practitioners
9. University of Colorado gets federal award for Cord Blood Bank
10. UC San Diego partners with Mozambique University to deliver quality health care
11. Better cholesterol drugs may follow Saint Louis University researchers breakthrough
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Revolution for Truth has ... to protect parental rights and civil liberties, and to restore transparency within government ... demonstration coincides with a press conference taking place Friday morning calling on President ...
(Date:3/28/2017)... ... March 28, 2017 , ... Medforce Technologies, Inc., ... to announce it has joined the National Association for Home Care and Hospice ... ill, disabled, and dying Americans of all ages and the caregiver who provide ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, a leading developer ... Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to ... with efforts by the American College of Surgeons, U.S. Department of Defense, Department ...
(Date:3/28/2017)... Switzerland (PRWEB) , ... March 28, 2017 , ... ... for laboratory instruments are critical to ensuring high-quality results and maintaining GMP and ... Qualification of Laboratory Instruments in accordance with GMP requirements " these requirements are ...
(Date:3/28/2017)... San Francisco, CA (PRWEB) , ... March 28, 2017 , ... ... million people suffering from acne, access to quality care can be limited while the ... skincare company that offers customized prescription acne care for every customer online, today released ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... The National University of Singapore (NUS) ... company, signed a Memorandum of Understanding (MOU) recently ... the region. Under this MOU, ... Technology (BIGHEART) at NUS and Holmusk will establish ... healthcare IT and medical device development. These include ...
(Date:3/27/2017)... 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage ... early toxicology and efficacy studies. The company is harnessing ... specific protein, MAGE A, in an effort to find ... After 4 weeks of treatment in transgenic ... little toxicity in a full toxicology report of various ...
(Date:3/27/2017)... , March 27, 2017  Sanderling Ventures, portfolio ... Ethicon, a division of Johnson & Johnson. Torax manufactures ... the treatment of gastro-esophageal reflux disease (GERD). The ... (MSA) technology and the procedure is currently available ... Torax Medical was founded by Sanderling Ventures, ...
Breaking Medicine Technology: